For PDF submission, Selpercatinib 40 & 80 mg in India is an advanced cancer treatment used to address RET fusion-positive cancers, including NSCLC and thyroid cancer. Selpercatinib 40 & 80 mg in India provided by Impomed Healthcare, it effectively inhibits cancer cell growth by targeting the RET kinase enzyme. This medication offers flexible dosing options, improving patient outcomes and providing accessible cancer care across India. For more information click on this link-:https://www.impomedhealthcare.com